XML 43 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair value measurement (Tables)
 9 Months Ended
Oct. 01, 2017
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Carried at Fair Value Measured on Recurring Basis
The following tables provide information regarding the Company's financial assets and liabilities that are measured at fair value on a recurring basis as of October 1, 2017 and December 31, 2016:
 
Total carrying
value at
October 1, 2017
 
Quoted prices in active
markets (Level 1)
 
Significant other
observable
Inputs (Level 2)
 
Significant
unobservable
Inputs (Level 3)
 
(Dollars in thousands)
Investments in marketable securities
$
8,563

 
$
8,563

 
$
—

 
$
—

Derivative assets
2,002

 
—

 
2,002

 
—

Derivative liabilities
330

 
—

 
330

 
—

Contingent consideration liabilities (1)
12,117

 
—

 
—

 
12,117

 
Total carrying
value at
December 31, 2016
 
Quoted prices in active
markets (Level 1)
 
Significant other
observable
Inputs (Level 2)
 
Significant
unobservable
Inputs (Level 3)
 
(Dollars in thousands)
Investments in marketable securities
$
7,660

 
$
7,660

 
$
—

 
$
—

Derivative assets
1,157

 
—

 
1,157

 
—

Derivative liabilities
2,257

 
—

 
2,257

 
—

Contingent consideration liabilities (1)
7,102

 
—

 
—

 
7,102


(1)
As of October 1, 2017 and December 31, 2016, (a) $0.6 million of contingent consideration liabilities were recognized in the current portion of contingent consideration, and (b) $11.5 million and $6.5 million of contingent consideration liabilities, respectively, were recognized in other liabilities in the condensed consolidated balance sheet.
Reconciliation of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis
The following table provides information regarding changes, during the nine months ended October 1, 2017, in Level 3 financial liabilities related to contingent consideration, which are described below in this Note 9 under "Valuation Techniques":
 
Contingent consideration
 
2017
 
(Dollars in thousands)
Balance - December 31, 2016
$
7,102

Additions (1)
5,369

Payment
(245
)
Revaluations
(109
)
Balance - October 1, 2017
$
12,117


(1) The Company established a liability related to the estimated fair value of contingent consideration associated with the Tianjin Medis acquisition.